European Consensus on Malabsorption—UEG & SIGE, LGA, SPG, SRGH, CGS, ESPCG, EAGEN, ESPEN, and ESPGHAN. Part 1: Definitions, Clinical Phenotypes, and Diagnostic Testing for Malabsorption
United European Gastroenterology Journal · 2025
DOI: 10.1002/ueg2.70012 ↗Kurz gefasst
Leitlinie in der Zeitschrift United European Gastroenterology Journal, 2025. Verfasst von Marco Vincenzo Lenti und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Italy. Hauptthemen laut MEDLINE: Gastroenterology, Malabsorption Syndromes. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: United European Gastroenterology, University of Pavia.
Abstract (Originalsprache)
Malabsorption is a complex and multifaceted condition characterised by the defective passage of nutrients into the blood and lymphatic streams. Several congenital or acquired disorders may cause either selective or global malabsorption in both children and adults, such as cystic fibrosis, exocrine pancreatic insufficiency (EPI), coeliac disease (CD) and other enteropathies, lactase deficiency, small intestinal bacterial overgrowth (SIBO), autoimmune atrophic gastritis, Crohn's disease, and gastric or small bowel resections. Early recognition of malabsorption is key for tailoring a proper diagnostic work‐up for identifying the cause of malabsorption. A patient's medical and pharmacological history is essential for identifying risk factors. Several examinations such as endoscopy with small intestinal biopsies, non‐invasive functional tests and radiological imaging are useful in diagnosing malabsorption. Because of its high prevalence, CD should always be looked for in cases of malabsorption with no other obvious explanations and in high‐risk individuals. Nutritional support is key in the management of patients with malabsorption; different options are available, including oral supplements, enteral or parenteral nutrition. In patients with short bowel syndrome, teduglutide proved effective in reducing the need for parenteral nutrition, thus improving the quality of life of these patients. Primary care physicians play a central role in the early detection of malabsorption and should be involved in multidisciplinary teams for improving the overall management of these patients. In this European consensus, involving ten scientific societies and several experts, we have dissected all the issues around malabsorption, including the definitions and diagnostic testing (Part 1), high‐risk categories and special populations, nutritional assessment and management, and primary care perspective (Part 2).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Italy.
- First Department of Internal Medicine, Fondazione IRCCS San Matteo, Pavia, Italy.
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University, Graz, Austria.
- 2nd Department of Internal Medicine - Gastroenterology, Faculty of Medicine in Hradec Králové, University Hospital Hradec Králové, Charles University, Hradec Kralove, Czech Republic.
- Endocrinology and Nutrition Department, Hospital Universitari Vall d'Hebron, Diabetes and Metabolism Research Unit, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autonoma de Barcelona, Barcelona, Spain.
- Gastroenterology and Nutrition, Centre Hospitalier Universitaire de Nice, Université Côte d'Azur, Nice, France.
ORCID-Profile: Marco Vincenzo Lenti, Heinz Florian Hammer, Stephane Schneider, Aleksejs Derovs, Jutta Keller, Ilse Broekaert, Juris Pokrotnieks, Johann Hammer, Loris Pironi, Juan Mendive, Denisa Kyselova, Lucrezia Laterza, Christos Lionis
Förderung
- United European Gastroenterology
- University of Pavia
Zitieren
APA
Lenti, M. V., Hammer, H. F., Tacheci, I., Burgos, R., Schneider, S., Foteini, A., Derovs, A., Keller, J., Broekaert, I., Arvanitakis, M., Dumitrascu, D. L., Segarra-Cantón, O., Krznarić, Ž., Pokrotnieks, J., Nunes, G., Hammer, J., Pironi, L., Sonyi, M., Sabo, C. M., …, & Di Sabatino, A. (2025). European Consensus on Malabsorption—UEG & SIGE, LGA, SPG, SRGH, CGS, ESPCG, EAGEN, ESPEN, and ESPGHAN. Part 1: Definitions, Clinical Phenotypes, and Diagnostic Testing for Malabsorption. United European Gastroenterology Journal. https://doi.org/10.1002/ueg2.70012
Vancouver
Lenti MV, Hammer HF, Tacheci I, Burgos R, Schneider S, Foteini A, et al. European Consensus on Malabsorption—UEG & SIGE, LGA, SPG, SRGH, CGS, ESPCG, EAGEN, ESPEN, and ESPGHAN. Part 1: Definitions, Clinical Phenotypes, and Diagnostic Testing for Malabsorption. United European Gastroenterology Journal. 2025. doi:10.1002/ueg2.70012
BibTeX
@article{Lenti2025,
author = {Lenti, Marco Vincenzo and Hammer, Heinz Florian and Tacheci, Ilja and Burgos, Rosa and Schneider, Stephane and Foteini, Anastasiou and Derovs, Aleksejs and Keller, Jutta and Broekaert, Ilse and Arvanitakis, Marianna and Dumitrascu, Dan Lucian and Segarra-Cantón, Oscar and Krznarić, Željko and Pokrotnieks, Juris and Nunes, Gonçalo and Hammer, Johann and Pironi, Loris and Sonyi, Marc and Sabo, Cristina Maria and Mendive, Juan and Nicolau, Adrien and Dolinsek, Jernej and Kyselova, Denisa and Laterza, Lucrezia and Gasbarrini, Antonio and Surdea-Blaga, Teodora and Fonseca, Jorge and Lionis, Christos and Corazza, Gino Roberto and Di Sabatino, Antonio},
title = {European Consensus on Malabsorption—UEG & SIGE, LGA, SPG, SRGH, CGS, ESPCG, EAGEN, ESPEN, and ESPGHAN. Part 1: Definitions, Clinical Phenotypes, and Diagnostic Testing for Malabsorption},
journal = {United European Gastroenterology Journal},
year = {2025},
doi = {10.1002/ueg2.70012}
}
EUVIMED